Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Pinnacle Discovers Silver-Lead-Zinc Mineralization Following up on LiDAR Survey at El Potrero (click to learn more) Sekur Private Data Signs Distribution Agreement In Africa (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Adhera Therapeutics Inc (EM) ATRX

Healthcare Biotechnology
Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson’s disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc... see more

Current News (EXPM:ATRX)

Adhera Therapeutics to Collaborate with Alberta Diabetes Institute, University of Alberta to Initiate Clinical Trial of MLR-1023 in Type 1 Diabetes

GlobeNewswire January 25, 2023

Adhera Therapeutics Announces CEO, Senior Management Changes, Plans for NASDAQ Uplist

GlobeNewswire September 19, 2022

Adhera Therapeutics Signs Letter of Intent to Acquire CD71-Targeted Cancer Therapy Paclitaxel Gallium Transferrin

GlobeNewswire July 19, 2022

Adhera Therapeutics Appoints Trond K. Waerness as Chairman of the Board, Company Focuses on Uplist to NASDAQ

GlobeNewswire May 19, 2022

Adhera Therapeutics Names Preeminent Diabetes Pioneer Dr. Jean Buteau to Scientific Advisory Board

GlobeNewswire March 21, 2022

Adhera Therapeutics Announces Uplisting to OTCQB Venture Marketplace

GlobeNewswire January 20, 2022

Adhera Therapeutics Receives Notice of Allowance for New Canadian Patent Covering MLR-1019 for Dyskinesia and Related Disorders

GlobeNewswire November 22, 2021

Adhera Therapeutics Announces Appointment of Dr. Zahed Subhan to Board of Directors

GlobeNewswire November 8, 2021

Adhera Therapeutics Expands Relationship with Melior Pharmaceuticals I, Adds NASH and Pulmonary Inflammation to Portfolio of Target Indications

GlobeNewswire October 20, 2021
View More News ››

Opinion & Analysis (EXPM:ATRX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (EXPM:ATRX)

Buy buddy buy.

Otherwise FOMO
coolfooldumbguy - September 23, 2025

Strong Fundamentals in $SAVA and $BOLT.CN

$SAVA’s innovative biotech pipeline positions it as a leader in addressing critical neurodegenerative diseases. Solid cash reserves...
TradeVision2001 - November 25, 2024

SAVA....and The Shorts win

Bad News for Bonzo the Bagholder
Iseneschal - November 25, 2024

SAVA Borrow Fee Sky High with 50% Float Sold Short Cover

SAVA Borrow Fee Sky High with 50% Float Sold Short Cover Buy to Cover Shorty
10QKing - November 25, 2024

SAVA 47% Float Sold Short Squeeze them force them to cover c

SAVA 47% Float Sold Short Squeeze them force them to cover currently down huge
10QKing - November 25, 2024

Cassava Sciences, Inc. (NASDAQ:SAVA): A Promising Alzheimer&

http://beyondspx.com/2024/08/02/cassava-sciences-inc-nasdaqsava-a-promising-alzheimers-candidate-facing-challenges/
MikeTester - August 3, 2024
View more Bullboard ››

Silver North Resources Ltd.

Silver North Resources Ltd.

Silver North Resources Ltd., an exploration stage company, acquires and explores mineral properties. It explores for gold ...
View More »

Podcasts